📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AKAM.
💹 Market Data
Market Cap$20.82B
Shares Outstanding145.39M
Float142.05M
Cash$968.78M
Debt$5.87B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 34.2% shares (2025Q4 vs prior)
685 institutional holders · 161.69M shares
#1
VANGUARD GROUP INC
18.35M shares
#2
BlackRock, Inc.
10.54M shares
#3
FIRST TRUST ADVISORS LP
6.75M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest15.79M
Days to Cover4.3
% of Float11.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2025
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AKAM
📊 AKAM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AKAM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.